Tonix Pharmaceuticals Holding (TNXP) Operating Margin Growth (3y) (2025)

Tonix Pharmaceuticals Holding (TNXP) Operating Margin Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.57 Bn 466.77 Bn 1.35 Bn 9,942.00
5 Vertex Pharmaceuticals 122.01 Bn 114.76 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn -623.00
9 Alnylam Pharmaceuticals 37.48 Bn 34.47 Bn 959.66 Mn 6,993.00
10 Tonix Pharmaceuticals Holding 141.11 Mn 141.11 Mn 5.30 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -19,102.00
Jun 30, 2025 -92,338.00